Women infected with SARS-CoV-2 during pregnancy are seven times more likely to die during childbirth or during the pregnancy than uninfected pregnant women.
The findings are from a post-hoc analysis of phase 2 and 3 clinical trial data from the study that showed propranolol was effective in the treatment of infantile hemangioma.